Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Clinical trial NCT01643668 · COMPLETED

Trial details

NCT number: NCT01643668
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome

Start date: 2012-07-01
Primary completion: 2016-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.